Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia: a comment
Crossref DOI link: https://doi.org/10.1007/s11096-019-00822-6
Published Online: 2019-04-09
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Davoudi-Monfared, Effat
Taghizadeh-Ghehi, Maryam http://orcid.org/0000-0003-0313-7670
Text and Data Mining valid from 2019-04-09
Article History
Received: 28 January 2019
Accepted: 4 April 2019
First Online: 9 April 2019